TY  - RPRT
TI  - [Drug utilization decisions should be based on cost-benefit data].
AU  - Jönsson Bengt
AU  - Göran Arvidsson
AU  - Lars-Ake Levin
AU  - Claes Rehnberg
UR  - https://pubmed.ncbi.nlm.nih.gov/15921102/
ID  - 15921102
ER  -